MedPath

Comparison of the effects of misoprostol and oxytocine on postpartum Hemorrhage

Phase 2
Conditions
Postpartum hemorrhage.
Other immediate postpartum haemorrhage
072.1
Registration Number
IRCT20100429003833N2
Lead Sponsor
Vice chancellor for Research,Tabriz University Of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
237
Inclusion Criteria

singleton pregnant women
elective cesarean delivery
Maximum history of once cesarean section

Exclusion Criteria

Preeclampsia
Cardiovascular diseases
Uterine myoma
A history of excessive bleeding after delivery.
Underlying disease, such as coagulopathy
Abnormal placental implantation (Placenta peria or Ecrta)

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Bleeding volume during cesarean section. Timepoint: After the placenta is removed until the uterus is repaired. Method of measurement: Number of gases and lumps of wet gases and volume of blood in suction.;Bleeding volume during the first 24 hours of cesarean section. Timepoint: Hemoglobin and hematocrit are measured 24 hours after surgery and compared with preoperative values. Method of measurement: blood test.;Duration of surgery. Timepoint: From the start of surgery to complete repair of the uterus. Method of measurement: Record start and end times.
Secondary Outcome Measures
NameTimeMethod
Drug side effects. Timepoint: From the time of hospitalization to the patient's discharge. Method of measurement: Control vital signs.
© Copyright 2025. All Rights Reserved by MedPath